- call +1-201-465-4211
- email sales@mrinsights.biz
Addison disease also called chronic adrenocortical insufficiency occurs because of the damaging of adrenal cortex resulting in insufficient production of hormone cortisol & aldosterone. The disease is characterized by symptoms such as weight lossdecreased appetiteextreme fatiguehyperpigmentationlow blood pressure and several others. Not treating the disease for the long time results in Addisonian crisis which is a life threatening medical emergency. People suffering from anticoagulantshaving cancerchronic infectionstuberculosis are more likely to be affected by the disease. Doctors look for the medical history and do physical examination as well as various laboratory tests for diagnosing the disease. Idiopathic autoimmune Addison disease is found to be more common in childrenfemales and in the people with age group of 30-50 years. Delaying in diagnosis and treatment of the disease may lead to high chances of morbidity and mortality.
Scope of the Report:
This report studies the Addison Disease Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Addison Disease Testing market by product type and applications/end industries.
The averageidence rate of Addison disease is roughly three in 1 million population in the world and is considered as one of the rare diseasehowever variation can be seen in different regions. RecentlyThe Endocrine Society has also issued its first ever clinical practice guideline on the diagnosis and treatment of primary adrenal insufficiency. Huge competition in the market is due to thereased number of service providers. High efficiency and less price on the testing service are the factors for survival in the market.
The global Addison Disease Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Addison Disease Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Diagnostic Laboratory Services
Any Lab Test Now
Dr Lal PathLabs
Laboratory of America Holdings
Sonora Quest Laboratories
Core Diagnostics
Ayumetrix
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Laboratory Testing
Imaging Studies
Market Segment by Applications, can be divided into
Hospitals
Clinics
Diagnostics Laboratories
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Addison Disease Testing Market Overview
1.1 Product Overview and Scope of Addison Disease Testing
1.2 Classification of Addison Disease Testing by Types
1.2.1 Global Addison Disease Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Addison Disease Testing Revenue Market Share by Types in 2017
1.2.3 Laboratory Testing
1.2.4 Imaging Studies
1.3 Global Addison Disease Testing Market by Application
1.3.1 Global Addison Disease Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostics Laboratories
1.4 Global Addison Disease Testing Market by Regions
1.4.1 Global Addison Disease Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Addison Disease Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Addison Disease Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Addison Disease Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Addison Disease Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Addison Disease Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Addison Disease Testing (2013-2023)
2 Manufacturers Profiles
2.1 Diagnostic Laboratory Services
2.1.1 Business Overview
2.1.2 Addison Disease Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Diagnostic Laboratory Services Addison Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Any Lab Test Now
2.2.1 Business Overview
2.2.2 Addison Disease Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Any Lab Test Now Addison Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Dr Lal PathLabs
2.3.1 Business Overview
2.3.2 Addison Disease Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Dr Lal PathLabs Addison Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Laboratory of America Holdings
2.4.1 Business Overview
2.4.2 Addison Disease Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Laboratory of America Holdings Addison Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sonora Quest Laboratories
2.5.1 Business Overview
2.5.2 Addison Disease Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sonora Quest Laboratories Addison Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Core Diagnostics
2.6.1 Business Overview
2.6.2 Addison Disease Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Core Diagnostics Addison Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Ayumetrix
2.7.1 Business Overview
2.7.2 Addison Disease Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ayumetrix Addison Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Addison Disease Testing Market Competition, by Players
3.1 Global Addison Disease Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Addison Disease Testing Players Market Share
3.2.2 Top 10 Addison Disease Testing Players Market Share
3.3 Market Competition Trend
4 Global Addison Disease Testing Market Size by Regions
4.1 Global Addison Disease Testing Revenue and Market Share by Regions
4.2 North America Addison Disease Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Addison Disease Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Addison Disease Testing Revenue and Growth Rate (2013-2018)
4.5 South America Addison Disease Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Addison Disease Testing Revenue and Growth Rate (2013-2018)
5 North America Addison Disease Testing Revenue by Countries
5.1 North America Addison Disease Testing Revenue by Countries (2013-2018)
5.2 USA Addison Disease Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Addison Disease Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Addison Disease Testing Revenue and Growth Rate (2013-2018)
6 Europe Addison Disease Testing Revenue by Countries
6.1 Europe Addison Disease Testing Revenue by Countries (2013-2018)
6.2 Germany Addison Disease Testing Revenue and Growth Rate (2013-2018)
6.3 UK Addison Disease Testing Revenue and Growth Rate (2013-2018)
6.4 France Addison Disease Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Addison Disease Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Addison Disease Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Addison Disease Testing Revenue by Countries
7.1 Asia-Pacific Addison Disease Testing Revenue by Countries (2013-2018)
7.2 China Addison Disease Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Addison Disease Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Addison Disease Testing Revenue and Growth Rate (2013-2018)
7.5 India Addison Disease Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Addison Disease Testing Revenue and Growth Rate (2013-2018)
8 South America Addison Disease Testing Revenue by Countries
8.1 South America Addison Disease Testing Revenue by Countries (2013-2018)
8.2 Brazil Addison Disease Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Addison Disease Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Addison Disease Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Addison Disease Testing by Countries
9.1 Middle East and Africa Addison Disease Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Addison Disease Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Addison Disease Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Addison Disease Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Addison Disease Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Addison Disease Testing Revenue and Growth Rate (2013-2018)
10 Global Addison Disease Testing Market Segment by Type
10.1 Global Addison Disease Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Addison Disease Testing Market Forecast by Type (2018-2023)
10.3 Laboratory Testing Revenue Growth Rate (2013-2023)
10.4 Imaging Studies Revenue Growth Rate (2013-2023)
11 Global Addison Disease Testing Market Segment by Application
11.1 Global Addison Disease Testing Revenue Market Share by Application (2013-2018)
11.2 Addison Disease Testing Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Diagnostics Laboratories Revenue Growth (2013-2018)
12 Global Addison Disease Testing Market Size Forecast (2018-2023)
12.1 Global Addison Disease Testing Market Size Forecast (2018-2023)
12.2 Global Addison Disease Testing Market Forecast by Regions (2018-2023)
12.3 North America Addison Disease Testing Revenue Market Forecast (2018-2023)
12.4 Europe Addison Disease Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Addison Disease Testing Revenue Market Forecast (2018-2023)
12.6 South America Addison Disease Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Addison Disease Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Addison Disease Testing Picture
Table Product Specifications of Addison Disease Testing
Table Global Addison Disease Testing and Revenue (Million USD) Market Split b
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
